Prim S.A. (PRM) - Net Assets

Latest as of December 2025: €137.64 Million EUR ≈ $160.92 Million USD

Based on the latest financial reports, Prim S.A. (PRM) has net assets worth €137.64 Million EUR (≈ $160.92 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€196.53 Million ≈ $229.77 Million USD) and total liabilities (€58.89 Million ≈ $68.85 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PRM asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets €137.64 Million
% of Total Assets 70.03%
Annual Growth Rate 7.05%
5-Year Change 13.31%
10-Year Change 36.49%
Growth Volatility 5.01

Prim S.A. - Net Assets Trend (2004–2025)

This chart illustrates how Prim S.A.'s net assets have evolved over time, based on quarterly financial data. Also explore Prim S.A. assets under control for the complete picture of this company's asset base.

Annual Net Assets for Prim S.A. (2004–2025)

The table below shows the annual net assets of Prim S.A. from 2004 to 2025. For live valuation and market cap data, see Prim S.A. stock valuation.

Year Net Assets Change
2025-12-31 €137.64 Million
≈ $160.92 Million
+6.75%
2024-12-31 €128.93 Million
≈ $150.74 Million
+2.47%
2023-12-31 €125.82 Million
≈ $147.10 Million
+5.11%
2022-12-31 €119.71 Million
≈ $139.95 Million
-1.45%
2021-12-31 €121.47 Million
≈ $142.01 Million
+8.71%
2020-12-31 €111.74 Million
≈ $130.64 Million
+0.62%
2019-12-31 €111.05 Million
≈ $129.83 Million
+2.03%
2018-12-31 €108.84 Million
≈ $127.24 Million
+2.61%
2017-12-31 €106.07 Million
≈ $124.00 Million
+5.18%
2016-12-31 €100.84 Million
≈ $117.90 Million
+9.32%
2015-12-31 €92.25 Million
≈ $107.85 Million
-0.45%
2014-12-31 €92.66 Million
≈ $108.33 Million
+9.33%
2013-12-31 €84.76 Million
≈ $99.09 Million
+8.38%
2012-12-31 €78.20 Million
≈ $91.42 Million
+8.33%
2011-12-31 €72.19 Million
≈ $84.39 Million
+6.98%
2010-12-31 €67.48 Million
≈ $78.89 Million
+8.45%
2009-12-31 €62.22 Million
≈ $72.74 Million
+14.39%
2008-12-31 €54.39 Million
≈ $63.59 Million
+11.23%
2007-12-31 €48.90 Million
≈ $57.17 Million
+15.53%
2006-12-31 €42.32 Million
≈ $49.48 Million
+17.90%
2005-12-31 €35.90 Million
≈ $41.97 Million
+9.14%
2004-12-31 €32.89 Million
≈ $38.45 Million
--

Equity Component Analysis

This analysis shows how different components contribute to Prim S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 251.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Retained Earnings €16.68 Million 12.12%
Common Stock €4.26 Million 3.09%
Other Components €116.70 Million 84.79%
Total Equity €137.64 Million 100.00%

Prim S.A. Competitors by Market Cap

The table below lists competitors of Prim S.A. ranked by their market capitalization.

Company Market Cap
Reach Subsea
OL:REACH
$222.20 Million
Brightcom Group Limited
NSE:BCG
$222.22 Million
Solar A/S
CO:SOLAR-B
$222.23 Million
Audix Corp
TW:2459
$222.23 Million
Sino AG
F:XTP
$222.06 Million
CN YUH.ED.CORP. HD-00001
F:2YU
$221.99 Million
Jarllytec Co Ltd
TWO:3548
$221.97 Million
Nextronics Engineering
TWO:8147
$221.96 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Prim S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 128,932,000 to 137,641,000, a change of 8,709,000 (6.8%).
  • Net income of 16,683,000 contributed positively to equity growth.
  • Dividend payments of 7,985,000 reduced retained earnings.
  • Share repurchases of 3,293,000 reduced equity.
  • Other comprehensive income decreased equity by 114,634,327.
  • Other factors increased equity by 117,938,327.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €16.68 Million +12.12%
Dividends Paid €7.99 Million -5.8%
Share Repurchases €3.29 Million -2.39%
Other Comprehensive Income €-114.63 Million -83.29%
Other Changes €117.94 Million +85.69%
Total Change €- 6.75%

Book Value vs Market Value Analysis

This analysis compares Prim S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 158.83x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 4.21x to 158.83x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2004-12-31 €3.05 €12.85 x
2005-12-31 €2.77 €12.85 x
2006-12-31 €3.26 €12.85 x
2007-12-31 €3.70 €12.85 x
2008-12-31 €3.54 €12.85 x
2009-12-31 €3.67 €12.85 x
2010-12-31 €3.97 €12.85 x
2011-12-31 €4.25 €12.85 x
2012-12-31 €4.62 €12.85 x
2013-12-31 €4.99 €12.85 x
2014-12-31 €5.42 €12.85 x
2015-12-31 €5.38 €12.85 x
2016-12-31 €6.03 €12.85 x
2017-12-31 €6.12 €12.85 x
2018-12-31 €6.28 €12.85 x
2019-12-31 €6.41 €12.85 x
2020-12-31 €6.45 €12.85 x
2021-12-31 €7.05 €12.85 x
2022-12-31 €7.02 €12.85 x
2023-12-31 €7.40 €12.85 x
2024-12-31 €7.58 €12.85 x
2025-12-31 €0.08 €12.85 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Prim S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 12.12%
  • The company shows good efficiency in utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 6.63%
  • • Asset Turnover: 1.28x
  • • Equity Multiplier: 1.43x
  • Recent ROE (12.12%) is below the historical average (12.77%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2004 14.42% 7.36% 0.98x 2.01x €1.45 Million
2005 15.91% 7.94% 0.92x 2.18x €2.12 Million
2006 17.85% 8.34% 1.10x 1.95x €3.32 Million
2007 20.57% 10.98% 1.07x 1.75x €5.17 Million
2008 18.21% 10.34% 1.02x 1.73x €4.47 Million
2009 16.13% 10.51% 0.96x 1.61x €3.81 Million
2010 12.64% 8.97% 0.86x 1.64x €1.78 Million
2011 12.34% 9.74% 0.78x 1.63x €1.69 Million
2012 11.68% 10.30% 0.85x 1.34x €1.31 Million
2013 11.37% 11.07% 0.80x 1.28x €1.16 Million
2014 10.75% 10.57% 0.81x 1.26x €695.54K
2015 11.60% 10.79% 0.85x 1.26x €1.48 Million
2016 12.99% 11.90% 0.86x 1.27x €3.01 Million
2017 13.10% 11.46% 0.88x 1.30x €3.29 Million
2018 12.97% 10.50% 0.97x 1.27x €3.24 Million
2019 10.10% 7.43% 1.01x 1.35x €112.93K
2020 6.19% 4.70% 0.90x 1.46x €-4.26 Million
2021 14.34% 10.34% 0.94x 1.48x €5.28 Million
2022 7.01% 4.25% 1.07x 1.55x €-3.58 Million
2023 10.07% 5.85% 1.08x 1.59x €90.80K
2024 8.47% 4.68% 1.23x 1.48x €-1.97 Million
2025 12.12% 6.63% 1.28x 1.43x €2.92 Million

Industry Comparison

This section compares Prim S.A.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.

No peer company data available for comparison.

About Prim S.A.

MC:PRM Spain Medical Instruments & Supplies
Market Cap
$255.60 Million
€218.63 Million EUR
Market Cap Rank
#16168 Global
#104 in Spain
Share Price
€12.85
Change (1 day)
-2.65%
52-Week Range
€10.65 - €13.90
All Time High
€14.34
About

Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic pr… Read more